Portrait of a man with Beauty by Buford branding.
Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
Longer, Thicker, Darker Lashes!

Longer, Thicker, Darker Lashes!

February 4, 2009

Excitement is in the air!

Every woman wants to have thick, dark, long lashes. And although there have been many products on the market, LATISSE™ is the first and only FDA-approved, science-based treatment for thin or insufficient number of eyelashes. Through several clinical studies, LATISSE™ has been proven to enhance the length, thickness and darkness of your eyelashes.

With regular use, patients can expect longer and thicker lashes from LATISSE™ without the hassle of applying artificial lashes.

Since this is a prescription, LATISSE™ is only available through a physician’s office.

Come see what the buzz is all about the experience longer, thicker lashes in just weeks!

Given this exciting news, we expect this product to sell out quickly and so BEAUTY by BUFORD is now offering pre-sales of LATISSE™ to its clients. For more information, please contact us by phone or email. But hurry…supplies are limited and going fast!

And for more information, see www.latisse.com

Dr. Buford is a nationally recognized trainer for Allergan and educates both physicians and physician extenders in the safe and effective use of BOTOX® Cosmetic, Juvederm®, and now LATISSE™.

Posted by BEAUTY by BUFORD

You Might Also Like

BEAUTY by BUFORD Image

Here’s What’s New at BEAUTY by BUFORD in Spring 2022

Apr 3, 2022
BEAUTY by BUFORD Image

Be Sure to Ask These Questions Before Getting Injectables

Mar 25, 2021
BEAUTY by BUFORD Image

What Technique Will My Injector Use? Injection Techniques for Optimal Outcomes

Oct 27, 2020

10459 Park Meadows Drive, Suite 100
Lone Tree, CO 80124

(303) 951-5829

Mon-Fri: 9 AM - 5 PM

4.9
from 394+ Reviews

© 2025 BEAUTY by BUFORD | All Rights Reserved

Plastic Surgery Marketing

Sitemap   |   Privacy Policy   |   Accessibility   |   Notice of Open Payment Database

Accessibility: If you are visually impaired or have some other impairment and you wish to discuss potential accommodations related to using this website, please contact our office at (303) 951-5829.

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.